LOCALIZED OSTEOSARCOMA
Clinical trials for LOCALIZED OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALIZED OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for LOCALIZED OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted drug boost chemo for osteosarcoma?
Disease control Recruiting nowThis trial is testing whether adding the targeted drug cabozantinib to standard chemotherapy (methotrexate, doxorubicin, and cisplatin) helps people with newly diagnosed osteosarcoma, a type of bone cancer. The study includes over 1,100 participants and aims to see if the combina…
Matched conditions: LOCALIZED OSTEOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Researchers track osteosarcoma treatments to find what works best
Knowledge-focused Recruiting nowThis study follows 120 patients with localized osteosarcoma (a bone cancer) to collect information on their treatments and outcomes. It does not test a new drug but observes standard care to learn which approaches lead to better survival and fewer side effects. The goal is to imp…
Matched conditions: LOCALIZED OSTEOSARCOMA
Sponsor: Italian Sarcoma Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC